Hawthorn 300 mg

Hawthorn 300 mg

Nature's Way4.6 (1,573 ratings)
Format:Capsule Quantity: 90 Capsule(s) · 90 servings
Goals

Product analysis

75 out of 100

Hawthorn 300 mg is an affordable, focused herbal option intended for heart-related support. Differing quantity declarations make it harder to compare the serving with clearly described hawthorn extracts.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Flavonoids are identified, but the preparation’s comparative quality remains uncertain. A generic hawthorn amount does not establish equivalence to a specific, well-defined extract.

Ingredient Transparency100

The hawthorn amount and flavonoid preparation are stated. Differing quantity declarations do not support assuming a single combined serving amount.

Value For Money100

The labeled serving has a low cost. The unclear combined amount limits how precisely that cost can be compared with other extracts.

Customer Satisfaction82

Customer ratings are generally positive across more than a thousand ratings. The feedback describes satisfaction without establishing effectiveness or safety.

Product Focus73

The single-herb formula has a clear heart-related purpose. Routine benefits remain uncertain because findings for specific hawthorn extracts do not automatically apply to this preparation.

Format
Capsule
Container
90 Capsule(s)
Per serving
$0.17
Customer rating
4.6 · 1,573 ratings
Report analysis

Goals

Heart Health
Impact
High effect
A- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic

Hawthorn has been studied in specific standardized preparations in clinical heart failure, with conflicting evidence. Those results do not establish a cardiac-tonic effect or routine prevention benefit for this declaration. The amount receives a partial contribution in the saved comparison, but generic hawthorn mass does not establish equivalence to the clinical extracts.

How this product is rated for Heart Health

Ingredient fit88

The relevant ingredients provide a focused heart-health connection. Declared amounts partly meet the saved amount references.
Goal fit
Relevant ingredients dominate the heart-health fit; links to other goals broaden the product's focus.
Dose adequacy
The declared amounts provide partial coverage of the saved references; these are exposure comparisons rather than proven treatment doses.

Pathways17

The strongest saved connection is endothelial nitric-oxide function. No pathway reaches the breadth threshold.
Depth
The strongest saved connection concerns endothelial nitric-oxide function, without establishing a corresponding clinical outcome.
Breadth
No assessed pathway reaches the saved breadth threshold.

Evidence66

Hawthorn provides the leading evidence contribution in the saved findings. The preparation check is satisfied for included ingredients, without establishing prevention of heart attacks or strokes.
Evidence strength
Hawthorn supplies the leading evidence contribution, subject to the ingredient's population and outcome limitations.
Studied preparation
Included ingredients satisfy the saved preparation check; this does not establish efficacy of the finished product.

Formulation logic100

No required partner is missing, and no configured conflict was matched. Included amounts clear the saved minimum comparison threshold.
Partner coverage
No required partner is missing from the included contributions.
Conflicts
No configured ingredient conflict was matched.
Effective doses
All included ingredients clear the saved minimum amount threshold; this cutoff does not establish effective cardiovascular treatment.
Study evidence
Hawthorn Supportive 27 studies
Impact
Highest effect
A- Ingredient FitD PathwaysB+ EvidenceA+ Formulation Logic
Hawthorn · 165 mg

Hawthorn receives a vascular contribution in the saved finding, but its routine cardiovascular benefit remains uncertain. The supplied clinical evidence concerns a specific WS 1442 extract in treated heart failure and did not significantly improve the primary cardiac-event outcome. A generic 465 mg per serving declaration does not establish that preparation, its composition or comparable benefit.

How this product is rated for Cardiovascular Support

Ingredient fit88

The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
The relevant ingredients dominate the formula, although the product may also be linked to other goals.
Dose adequacy
The disclosed amounts provide partial support; smaller or unresolved quantities limit the amount finding.

Pathways47

The strongest recorded coverage concerns vascular tone and sodium balance; this is a mechanism finding, not proof of fewer cardiovascular events.
Depth
The strongest recorded coverage concerns vascular tone and sodium balance; this is a mechanism finding, not proof of fewer cardiovascular events.
Breadth
One cardiovascular mechanism reaches the coverage threshold, with limited coverage of the others.

Evidence81

Hawthorn provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
Hawthorn provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.

Formulation logic100

The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Study evidence
Hawthorn Supportive 28 studies

Ingredients

IngredientAmount per servingScore
Hawthorn (leaf and flower) extract (Flavonoids)
300 mg 71
Hawthorn
165 mg 71
Gluten Free Adults 18–50 Vegan Dairy Free Sugar Free Vegetarian
Report overview
C- Composition And Label DisclosureA+ Commercial Price And Usability
One capsule combines 300 mg of hawthorn leaf and flower extract with 165 mg from a separate hawthorn entry. The extract has a 1.8% standardization figure, but the saved facts do not name the marker.
How this ingredient is rated

Composition and Label Disclosure56

The 300 mg extract has a 1.8% standardization figure; the marker is unnamed. The separate 165 mg hawthorn entry has no marker percentage in the saved facts. The hawthorn species is not identified in the saved facts.
Marker and Preparation Disclosure
The 300 mg extract has a 1.8% standardization figure; the marker is unnamed. The separate 165 mg hawthorn entry has no marker percentage in the saved facts.
Species Name Disclosure
The hawthorn species is not identified in the saved facts.

Composition and Label Disclosure

No dose or safety rules were evaluated for hawthorn.

Commercial Price and Usability100

A whole-product serving costs about $0.17. Serving prices alone do not establish equivalent hawthorn amounts.
Commercial Price per Labeled Serving
The whole-product serving costs about $0.17.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
    Wyss C; Gündling PW; Kostev K · Scientific reports · 2024
    Cohort study9,100 participantsCardiovascular Support forHawthorn
  2. Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
    Szikora Z; Mátyus RO; Szabó BV; Csupor D; Tóth B · Pharmaceuticals (Basel, Switzerland) · 2025
    Meta-analysis428 participants6 studies pooledCardiovascular Support Heart Health forHawthorn
  3. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2003
    Randomized trial143 participantsCardiovascular Support forHawthorn
  4. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J · Fortschritte der Medizin · 1996
    Randomized trial136 participantsCardiovascular Support forHawthorn
  5. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M · Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine · 2005
    Cohort study952 participantsCardiovascular Support forHawthorn
  6. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK · Arzneimittel-Forschung · 2001
    Randomized trial88 participantsHeart Health forHawthorn
  7. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E · The American journal of medicine · 2003
    Meta-analysis632 participants13 studies pooledHeart Health forHawthorn
  8. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2002
    Randomized trial40 participantsHeart Health forHawthorn
  9. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Meta-analysis687 participants10 studies pooledHeart Health forHawthorn